3. Pathology of the female reproductive tract 3 Flashcards

1
Q

What is the most common presentation of endometrial cancer?

A

post-menopausal bleeding - 80% of women with endometrial cancer present with this

Tells us that most women with endometrial cancer are post-menopausal and that we should always investigate post menopausal bleeding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Describe the endometrium

A

Composed of glands in a specialised stroma with a specialised blood supply
Growth, maturation and regression of all three components is co-ordinated during each menstrual cycle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What tissue type most commonly gives rise to endometrial cancer

A

The predominant endometrial cancer arises in the glands of the endometrium

Malignant neoplasm of glandular epithelium = adenocarcinoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Adenocarcinomas

A

Adenocarcinomas arising at different sites in the body have different risk factors, pathogenesis, appearances, genetic abnormalities, behaviour, prognosis and treatment.
Among adenocarcinomas arising at a single site there are multiple subtypes, initially divided by different appearances and increasingly supplemented by understanding molecular genetic pathogenesis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

subtypes of endometrial adenocarcinoma by morphology

A
Endometrioid
Serous
Clear cell
Mixed (components of the previous 3)
Undifferentiated
Carcinosarcomas

*morphology means microscopic appearance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What do endometrioid adenocarcinomas look like?

A

Endometrioid because it looks like endometrium

Named for the resemblance of malignant glands to ordinary endometrial glands

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Why are the adenocarcinoma subtypes named endometrioid, serious, clear cell?

A

Endometrioid cancers show differentiation that resembles endometrial glands

Serous cancers were thought to resemble Fallopian tube epithelium

Clear cell cancers have clear cytoplasm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Why is naming adenocarcinomas tricky?

A

Adenocarcinoma subtypes with similar appearance and the same names occur at other sites
eg there is a clear cell carcinoma of the ovary
They are NOT the same disease
If a tumour has spread to other sites it can be very difficult to work out which is the site of origin and which is the site of metastasis

We know that there are different microscopic morphologic types of endometrial adenocarcinoma.
Does the appearance of the tumours reflect any biological difference in their cause and behaviour?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How do the two main groups of women with endometrial adenocarcinoma differ?

A
The two groups differ with respect to
Cause
Age
Morphologic types of tumour
Molecular genetic abnormalities
Precursor lesions
Prognosis and treatment
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Type 1 of women who typically get endometrial cancer

A
50s – 60s
Obesitycommon
Estrogenic stimulation common
Endometrial background -anovulatory
Precursor lesion - EIN, atypical hyperplasia
Transition - Slow
Type - Endometrioid
Molecular genetics -MSI, PTEN, PAX2 loss
Familial - HNPCC
Spread - Lymph nodes
Concurrent ovarian ca is common
Prognosis - Good
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Type 2 of women who get endometrial cancers

A
60s – 70s
Obesity uncommon
Estrogenic stimulation uncommon
Endometrial background- atrophic
Precursor lesion - EIC
Transition - unknown
Type- Serous, mixed
Molecular genetics - P53 mut, 1p deletion, PAX2 loss

Spread- Peritoneum
Concurrent ovarian ca is uncommon
Prognosis is poor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the TCGA

A

The cancer genome atlas (TCGA) published an integrated genomic classification of endometrial cancer in 4 groups
Based on integrated genomic, transcriptomic and proteomic characterisation of c370 endometrial carcinomas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

TCGA endometrial cancers

A

Ultramutated cancers (DNA pol epsilon mutations) 7%

Hypermutated cancers (defective mismatch repair and microsatelite instability) 28%

Endometrial cancers with low frequency of DNA copy number alterations 39%

Endometrial cancers with high frequency of DNA copy number alterations 26%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Precursor lesions in endometrial adenocarcinoma

A

In the cervix, we recognize a precursor lesion to invasive squamous cell carcinoma
Cervical Intra-Epithelial Neoplasia (CIN)
The disease process is called dysplasia

How do we detect CIN and treat it to prevent cervical carcinoma?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Most common type of precursor lesion in endometrium

A

It is assumed that the common (endometrioid) form of endometrial carcinoma has its origin in a lesion called atypical hyperplasia
This is supported by temporal, genetic and morphologic continuity with endometrioid endometrial adenocarcinoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

The women at risk of endometrial adenocarcinoma

A

Most common invasive cancer of the female genital tract in UK
Fourth most common cancer in women in the UK (breast, lung, colorectum)
Lifetime risk of 1 in 46
Usually arises in postmenopausal women
Peak incidence in the 55-65 y/o age group
Most common presenting feature is postmenopausal bleeding (c80%)

17
Q

Risk factor for endometrial cancer

A
Endogenous hormones and reproductive factors
Excess body weight
Diabetes mellitus and insulin
Exogenous hormones & modulators
Ethnicity
Familial (Cowden’s syndrome; HNPCC)
Smoking not a risk
18
Q

How do endogenous hormones contribute to endometrial cancer risk?

A

Excess exposure to estrogen unopposed by progestagens
Overweight increases estrogen levels in post menopausal women
Overweight can disrupt ovulation and progestagen production in pre menopausal women
Polycystic ovarian disease
Some rare ovarian neoplasms can produce estrogens

19
Q

Reproduction as a risk factor for endometrial cancer

A

Pregnancy and parity reduce the risk of endometrial cancer
Mechanism includes the break from unopposed oestrogen during pregnancy and the removal of abnormal cells at delivery
Early menarche and late menopause increase risk (reduced by 7% for each year fewer)

20
Q

Excess body weight as a risk factor for endometrial cancer

A

c 34 % endometrial cancers are linked to excess body weight
2-3 times increased risk in overweight women
Increased risk begins with a moderately elevated BMI
Central adiposity (waist circumference and waist:hip ratios) may be more important than BMI

21
Q

Diabetes mellitus as a risk factor for endometrial cancer

A

Women with diabetes mellitus have a two-fold increased risk of endometrial cancer
Hard to separate effect of insulin from excess body weight but a probably direct effect
Insulin and insulin-like growth factors may increase the effects of estrogen on the endometrium

22
Q

Exogenous hormones and modulators as a risk factor

A

Hormone replacement therapy
- Unopposed estrogen (RR 6.0)
Tamoxifen (RR 2.0)

23
Q

Ethnicity as a risk factor

A
US studies show endometrial carcinoma is less common in African American women
13 per 105 in African-American women
23 per 105 in white 
BUT this group has higher mortality (x4)
Many variables involved
Later stage at diagnosis
Unfavourable tumour type
Sociodemographic factors and treatment
Comorbidities
24
Q

Parameters informing behaviour and treatment

A

There are three tumour-specific parameters
Tumour type
Tumour grade
Tumour stage

25
Q

Grading neoplasms

A

Grading reflects how much a tumour resembles its parent tissue
Has to be done on tissue under a microscope
Many use a three-point system

Well differentiated Grade 1
Moderately differentiated Grade 2
Poorly differentiated Grade 3

26
Q

Grading endometrial carcinoma

A

Normal endometrial epithelium matures to form glands
Adenocarcinomas also form glands
The fraction of the tumour forming glands is estimated as a percentage
(then divided into three groups)
Tumour grade affects prognosis

27
Q

Staging systems

A

For all neoplasms a T N M system exists
T for tumour: local spread
N for nodes: lymph node deposits
M for metastasis: metastatic deposits

For gynaecological tumours a different system called FIGO is usually used

28
Q

Spread of endometrial carcinoma

A

Because endometrium has its own stroma, initially malignant glands invade endometrial stroma
Then spreads into the myometrium
Down into the cervix
Where it reaches vessels and spreads via lymphatics or veins to nodes or vagina

29
Q

FIGO staging of endometrial carcinoma

A

Stage 1: Confined to corpus
Stage 2: Involving cervix
Stage 3: Serosa/Adnexa/Vagina/Lymph Nodes
Stage 4: Bladder, Bowel, Distant Metastasis

30
Q

Endometrial cancer overview

A

Over 80% of women with endometrial cancer present with post menopausal bleeding
Most ‘endometrial cancers’ arise from endometrial glands and are adenocarcinomas
There are several different types of adenocarcinoma – the most common is called endometrioid because it resembles endometrial glands

31
Q

How can other types of endomtrial (non endometrioid) adenocarcinomas be recognised?

A

Other types of endometrial adenocarcinoma can be recognized microscopically
These may have distinct molecular abnormalities and behaviour
Recognizing different types of adenocarcinoma benefits patients since it informs likely prognosis and treatment

32
Q

Endometrioid cancer precursors

A

Endometrioid cancer has a precursor lesion called atypical hyperplasia
Tumour grading estimates the degree to which the neoplasm matures and informs prognosis and treatment
Tumour staging demonstrates the extent to which a neoplasm has spread and informs prognosis and treatment